Development and validation of a melatonin radioimmunoassay using radioiodinated melatonin as tracer

in European Journal of Endocrinology
Restricted access

Abstract. A new radioimmunoassay (RIA) using [125I]melatonin as tracer for determination of melatonin in biological fluids has been developed. Melatonin antisera were raised in rabbits by immunization with bovine thyroglobulin conjugate of n-acetyl-5-methoxytryptophan. Two high-affinity and specific antisera were obtained. Unlike in previous studies melatonin was radioiodinated directly. Iodo-Gen was used as the oxidant. Radioiodinated melatonin was purified by TLC for use in RIA. Melatonin was extracted from plasma, serum and urine samples (1 ml) with chloroform. Using the extraction the sensitivity of the RIA method was 18 fmol/ml of original sample. Plasma, serum and urine extracts diluted parallelly with synthetic melatonin in RIA. HPLC analysis of plasma and serum extracts showed only one immunoreactive peak co-eluting with synthetic melatonin. Majority of urine immunoreactivity co-eluted with synthetic melatonin, but 7–23% contaminating immunoreactivity was also observed. Daytime values for rat plasma, human serum and urine melatonin were 30–60, 20–40 and 50–130 fmol/ml and the respective night values were 160–300, 180–370 and 230–470 fmol/ml. Thus a characteristic diurnal rhythm of melatonin was observed in all cases. The urinary excretion of immunoreactive melatonin during the day was 3–9 and during the night 11–28 pmol/h. Thus we have developed a specific and valid RIA method for the determination of plasma and serum melatonin. Despite the incomplete specificity of the RIA for urine determinations, a clear diurnal rhythm for urine melatonin was observed. The distinct advantage of the utilization of [125I]melatonin as tracer is that the costly and cumbersome scintillation counting can be avoided.


     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 403 109 9
Full Text Views 104 6 0
PDF Downloads 94 7 0